Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
by The Investment U Research Team
There has been a lot of news on tech bellwether Microsoft (Nasdaq: MSFT) recently – most of it negative. The stock took a nosedive on Friday after reporting quarterly profit had dropped.
The news ranges from Microsoft forced to add other browsers to its software to avoid antitrust issue in the EU, to its bottom line harmed by netbooks and the broader economy.
This doesn’t even get into the ignored weakness in the tech sector.
Far from out, Microsoft is a phenomenal buy right now. Friday’s drubbing makes the stock even more attractive – from a growth or income perspective.
We’ve talked before about Microsoft’s Windows 7, but let’s get more to the point of profits. We know many individuals and businesses are waiting for this new version to upgrade their current Windows XP. When it rolls out, it should have an immediate impact on the bottom line.
And as much as MSFT has been trying to diversify around the tech segment, including video games and browsers, software is still their main bread and butter.
Win 7 should give us a good indicator for the strength of Microsoft. If it does well, you’re sure to see headlines like “Sleeping Giant Wakes Up,” and Microsoft Back in the Game with Win 7.”
The fact is, Bill Gates baby is doing just fine as an adolescent, and while recently down, should never be counted out.
Symbols mentioned in this article: MSFT
- Video Game Slump Nothing New
- Google Takes MSFT Head on
- Microsoft’s (Nasdaq: MSFT) Miss Shouldn’t Surprise
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed